Albaclone anti-a
Ended Awarded Last action
- Contract number
- SPE2D626F16N6
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,422
Award facts
- Contract value 100% obligated
- $1,422.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $1,422.00 delivery order contract to Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics specializing in in vitro diagnostic products and blood banking materials. The award, issued on December 12, 2025, with an ultimate completion date of December 17, 2025, is for ALBACLONE Anti-A monoclonal antibodies used in blood typing and immunohematology testing. This firm fixed-price delivery order carries no set-aside designation and will be performed in Chicago, Illinois. Alba Bioscience competes in the federal marketplace based on its specialized capabilities rather than small business preferences, reflecting the competitive nature of its highly technical immunohematology product portfolio.
This delivery order is issued under one of Alba Bioscience's existing Blanket Purchase Agreements with the Department of Veterans Affairs, which serve as indefinite delivery vehicles for blood banking supplies and diagnostic reagents. The company maintains two significant BPAs with the VA under GSA Schedule 65-VII—one valued at $199,671.75 through May 2030 with Veterans Integrated Service Network 15, and another valued at $218,840.70 through September 2026 with Veterans Integrated Service Network 10. These agreements enable VA medical facilities across the integrated healthcare system to efficiently procure critical blood banking supplies including monoclonal antibodies, antibody identification panels, screening products, quality control kits, and additive solutions through streamlined task order processes.
Quick answers
Who was awarded contract SPE2D626F16N6?
SPE2D626F16N6 was awarded to Alba Bioscience, Inc. by Medical Supply Chain (Troop Support) on December 12, 2025.
How much is contract SPE2D626F16N6 worth?
The government has obligated $1,422 on SPE2D626F16N6.
Is contract SPE2D626F16N6 an order under another contract?
Yes. SPE2D626F16N6 is a delivery order under SPE2DE22D0008, an indefinite delivery contract.
Was contract SPE2D626F16N6 competed?
The extent of competition for SPE2D626F16N6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award